Free Declaration in Support - District Court of California - California

Case 3:O7—cv—O2845-WHA Document 63-4 FiIed12/06/2007 Page10f2

· Case 3:07—cv—02845-WHA Document 63-4 Filed 12/06/2007 Page 2 of 2
` P A- SHORT HISTORY OF APPLIED BIOSYSTEMS,. INC. - `
. Applied Biosystemsis a leading supplier of systems and-services for life science research and -
related applications. The Company develops, manufactures, and markets automated instruments I .
and associated consumables for the synthesis, purification, and analysis of biornolecules such as
DNA and proteins. The Company was incorporated_in September of 1980. and began_ its -
operations in California in May of 1981. It currently employs nearly 1300 people. André Marton,
. who serves as the Chief Executive Officer and Chairman of the Board, co-founded the Company
S with Sara Eletr and others. The first product was shgiped in February of 1982. In fiscal·1991, __ ·
(from July 1, 1990 to June 30, 1991) total-sales of $1 4 million were divided among instruments ‘
(53%) and consumable/service/other products—(47%). . · -
_ n The initial public offering of Applied Biosystems' stock was made in 1983 at $17.00 per share, S .
and split two·for—one in March, 985. The stock is `traded on the NASDAQ`exchange under the
symbol ABIO. Becton Dickinson and Company owns 20% of the stock. ‘ . .
A . The Company traditionally invests heavily (at least 12% of sales) in research and development. . _ ‘
A Applied Biosystems' product development strategy is to acquire existing technologies that are
; readily adaptable to its markets and to focus its R&D resourccson areas that require entirely-new
developments. The Protein Sequencing System, introduced in 1982, was`Applied Biosystems' `
_ first product. Today, Applied- Biosystems offers over 25 automatedjsystems for the synthesisand p- .
analysis of protein and DNA molecules. Instrument systems are manufactured in the United ·
. States. Chemicals and consumables are produced inthe United States, Japan, and the United
- _ Kingdom. S _ . - _ . ` _
` _ Applied Biosystems' primary targeted market, life science_ is international in scope; It's . M _
, ’ principal customers are molecular biologists and biochemists at both public and private institutions.
_ The Company maintains eight international sales and service subsidiaries, As ofthe end of fiscal _
1991, 90% of the Applied Biosystems' sales were directly made with customers through the
_ _ , Company's sales personnel. Sales in the United States accounted for 45% of the total in fiscal
_ 1991, with the balance coming from Europe (29%),- Japan (19%), and other regions of the world . .
~ (7%). - . ‘ ` `
Fiscal 1991 revenues were contributed by researchers at universities (40%), government
institutions (20%). pharmaceutical companies (16%), and other sources, including chemical and -
biotechnology companies (24%). · _ `
In addition to serving its primary market, Applied Biosystems also participates in the applications
` of basieresearch in areas such as the detection of gcnetic_ diseases and the development of DNA
‘ analogs for the treatment of human disease. The Company is currently exploring the use of ‘
—proprietary analysis technology for the diagnostics mar et. Research programs exploring the ·
potential of anti-sense oligonucleotidesas therapeutics began at Applied Biosystems in 986. .
The Company believes in total respect for the dignity and rights of each person in the organization,
in giving the best customer service of any company in the world, and in the conviction that it _
should pursue all tasks with the objective of accomplishing them in a superior way. Applied
Biosystems is strongly committed to supply innovative and complete solutions to its customers, ’
and long term opportunities for its employees and shareholders. .
- A csrousa ‘ . 4 - - T
` S S S MAC001127 {

Case 3:07-cv-02845-WHA

Document 63-4

Filed 12/06/2007

Page 1 of 2

EXHIBIT 3

Case 3:07-cv-02845-WHA

Document 63-4

Filed 12/06/2007

Page 2 of 2